
Sign up to save your podcasts
Or


Today, I'm joined by Ariana Thacker, founder and CEO of MoldCo.
Born from personal experience, the company is revolutionizing treatment for mold-related illness by combining specialized testing, personalized protocols, and ongoing R&D.
In this episode, we discuss building a healthcare platform for mold toxicity.
We also cover:
• Mold exposure's impact on 30–40M Americans • Making the "Shoemaker Protocol" treatment more accessible • Building a company that bridges care delivery with cutting-edge research
Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider Website: https://www.moldco.com/
IG: https://www.instagram.com/themoldcompany/
-
The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.
Fitt Talent: https://talent.fitt.co/
Consulting: https://consulting.fitt.co/
Investments: https://capital.fitt.co/
Chapters: (00:00) Introduction (01:40) Ariana's journey to MoldCo (03:20) Identifying mold exposure (04:40) The prevalence of mold issues in homes and buildings (06:00) Understanding mold toxicity symptoms and biomarkers (07:40) The broken healthcare journey for mold patients (10:20) Finding evidence-based solutions with the Shoemaker protocol (12:40) Market size and impact (14:40) From VC to founder (18:20) Raising capital for an unconventional healthcare startup (21:20) Growing mainstream awareness of environmental toxins (23:20) Pioneering the standard of care for mold toxicity (25:40) Using existing medications versus developing new treatments (29:40) Expanding beyond mold (32:00) Current operations and patient experience (35:00) Nationwide expansion plans (36:00) Making lab testing affordable and accessible (37:40) Conclusion
By Joe Vennare4.9
8686 ratings
Today, I'm joined by Ariana Thacker, founder and CEO of MoldCo.
Born from personal experience, the company is revolutionizing treatment for mold-related illness by combining specialized testing, personalized protocols, and ongoing R&D.
In this episode, we discuss building a healthcare platform for mold toxicity.
We also cover:
• Mold exposure's impact on 30–40M Americans • Making the "Shoemaker Protocol" treatment more accessible • Building a company that bridges care delivery with cutting-edge research
Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider Website: https://www.moldco.com/
IG: https://www.instagram.com/themoldcompany/
-
The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.
Fitt Talent: https://talent.fitt.co/
Consulting: https://consulting.fitt.co/
Investments: https://capital.fitt.co/
Chapters: (00:00) Introduction (01:40) Ariana's journey to MoldCo (03:20) Identifying mold exposure (04:40) The prevalence of mold issues in homes and buildings (06:00) Understanding mold toxicity symptoms and biomarkers (07:40) The broken healthcare journey for mold patients (10:20) Finding evidence-based solutions with the Shoemaker protocol (12:40) Market size and impact (14:40) From VC to founder (18:20) Raising capital for an unconventional healthcare startup (21:20) Growing mainstream awareness of environmental toxins (23:20) Pioneering the standard of care for mold toxicity (25:40) Using existing medications versus developing new treatments (29:40) Expanding beyond mold (32:00) Current operations and patient experience (35:00) Nationwide expansion plans (36:00) Making lab testing affordable and accessible (37:40) Conclusion

16,210 Listeners

532 Listeners

2,714 Listeners

2,185 Listeners

3,993 Listeners

8,700 Listeners

668 Listeners

2,661 Listeners

152 Listeners

29,389 Listeners

209 Listeners

1,374 Listeners

598 Listeners

653 Listeners

59 Listeners